LRP4: A new bone anabolic drug target? Blog Post from ASBMR Scientific Web Editor Joe Lorenzo
Date: January 06, 2015
In his latest blog post, ASBMR Scientific Web Editor Joe Lorenzo, M.D., discusses bone anabolic agents to treat osteoporosis. He addresses LRP4 levels and its relation to osteoblasts and osteocytes, as a binding protein. Read his full blog post here.